Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Net Short-Term Debt Issued (Repaid) (2012 - 2026)

Updated

Phibro Animal Health (PAHC) reported Net Short-Term Debt Issued (Repaid) of $141 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 143.1% from $58 million a year earlier and up 88.0% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Net Short-Term Debt Issued (Repaid) (2012 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Phibro Animal Health's Net Short-Term Debt Issued (Repaid) came in at $427 million, up 15.4% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $276.41 million, down 56.0% from FY2025.

  • Net Short-Term Debt Issued (Repaid) has a five-year compound annual growth rate of -6.7% (FY2021 to FY2026).
  • By fiscal year, Net Short-Term Debt Issued (Repaid) came in at $628.53 million in FY2025 (+34.1%), $468.59 million in FY2024 (+70.8%), $274.36 million in FY2023 (+11.1%) and $247 million in FY2022 (-36.9%).
  • Five-year quarterly Net Short-Term Debt Issued (Repaid) spans a low of $36 million in fiscal Q3 2022 and a high of $264 million in fiscal Q1 2025.
  • Year over year, Net Short-Term Debt Issued (Repaid) has now increased in each of the last three quarters, with growth averaging 47.6% over the last eight quarters.
  • The high point for year-over-year Net Short-Term Debt Issued (Repaid) in five years was fiscal Q1 2025 (growth of 594.7%); the low point was fiscal Q3 2025 (a decline of 78.0%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $75 million (Q4 2026), $141 million (Q3 2026) and $70 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.28 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -499.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -682.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -87.00 Mn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 141.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 141.00 Mn
Jun 30, 2026 75.00 Mn
Mar 31, 2026 141.00 Mn
Dec 31, 2025 70.00 Mn
Sep 30, 2025 58.00 Mn
Jun 30, 2025 58.00 Mn
Mar 31, 2025 58.00 Mn
Dec 31, 2024 196.00 Mn
Sep 30, 2024 264.00 Mn
Jun 30, 2024 115.90 Mn
Mar 31, 2024 264.00 Mn
Dec 31, 2023 45.00 Mn
Sep 30, 2023 38.00 Mn
Jun 30, 2023 87.00 Mn
Mar 31, 2023 38.00 Mn
Dec 31, 2022 122.00 Mn
Sep 30, 2022 36.00 Mn
Jun 30, 2022 61.00 Mn
Mar 31, 2022 36.00 Mn
Dec 31, 2021 80.00 Mn
API Access

Phibro Animal Health Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=PAHC&period=max&api_key=YOUR_API_KEY